NYSE: PJTPjt Partners Inc Stock
$178.63+2.48 (+1.41%)
Updated Jul 10, 2025
PJT Price
$178.63
Fair Value Price
N/A
Market Cap
$4.36B
52 Week Low
$112.20
52 Week High
$190.28
P/E
29.14x
P/B
29.32x
P/S
2.37x
PEG
N/A
Dividend Yield
0.56%
Revenue
$1.49B
Earnings
$155.79M
Gross Margin
100%
Operating Margin
11.14%
Profit Margin
10.5%
Debt to Equity
3.85
Operating Cash Flow
$494M
Beta
0.86
Next Earnings
Jul 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PJT Overview
PJT Partners Inc. offers advisory services in the areas of capital markets strategy, restructuring and special situations to corporations, financial sponsors, institutional investors, and governments in the U.S. and internationally. Other advisory services are offered in the areas of mergers and acquisitions, spin-offs, activism defense, joint ventures, minority investments, and divestitures. It also provides private fund advisory and fundraising in support of investment strategies. PJT Partners was incorporated in 2014 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PJT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Capital Market
Industry Rating
D
PJT
Ranked#16 of 57
Ranked#16 of 57
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.66 | A | |
| $10.43 | A | |
| $3.95 | B |
Be the first to know about important PJT news, forecast changes, insider trades & much more!
PJT News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PJT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PJT is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PJT is good value based on its earnings relative to its share price (29.14x), compared to the US market average (30.8x)
P/E vs Market Valuation
PJT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PJT due diligence checks available for Premium users.
Valuation
PJT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.14x
Industry
22.69x
Market
30.8x
PJT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PJT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PJT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
29.32x
Industry
2.59x
PJT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PJT's financial health
Profit margin
Revenue
$324.5M
Net Income
$54.0M
Profit Margin
16.6%
PJT's Earnings (EBIT) of $165.77M... subscribe to Premium to read more.
Interest Coverage Financials
PJT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.4B
Liabilities
$572.4M
Debt to equity
3.85
PJT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PJT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$75.9M
Investing
$28.0M
Financing
-$245.0M
PJT's operating cash flow ($493.79M)... subscribe to Premium to read more.
Debt Coverage Financials
PJT vs Capital Market Stocks
Pjt Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.